Aman Chauhan: We will continue to work on NEC and SCLC and hopefully find a breakthrough

Aman Chauhan, Leader of Neuroendocrine Cancer Program at the Sylvester Comprehensive Cancer Center, shared on his Twitter:

“High-grade NEC is among the toughest cancers to treat. I had a great time collaborating with Dr. Anish Thomas and help in accrual for this ATRi study. Please check out our work just published in JAMA Oncology. We will continue to work on NEC and SCLC and hopefully find a breakthrough. Promising studies on the horizon. Stay tuned!! ”

For the article click here.

Source: Aman Chauhan/Twitter